Key stats
About VANECK GENOMICS N HEALTHCA INN UCITS ETF
Expense ratio
0.35%
Home page
Inception date
Sep 2, 2022
ISIN
IE000B9PQW54
The Funds investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Technology Services
Health Services
Stocks99.71%
Health Technology71.96%
Technology Services13.82%
Health Services11.87%
Distribution Services1.03%
Electronic Technology0.53%
Commercial Services0.29%
Retail Trade0.21%
Bonds, Cash & Other0.29%
Cash0.29%
Stock breakdown by region
North America88.13%
Asia5.33%
Oceania3.66%
Europe2.89%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history